perillyl alcohol has been researched along with Disease Exacerbation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carvalho, Mda G; Carvalho, PC; da Fonseca, CO; Domont, GB; Fischer, Jde S; Neves-Ferreira, AG; Perales, J | 1 |
| Bailey, H; Berlin, J; Kolesar, J; Meadows, SM; Mulkerin, D; Thomas, JP; Warren, D | 1 |
| Caetano, R; Da Fonseca, CO; Futuro, D; Gattass, CR; Masini, M; Quirico-Santos, T | 1 |
| Attia, S; Bailey, HH; Chappell, R; Fass, T; Hansen, R; Harris, L; Jumonville, A; Love, RR; Shapiro, GR; Stewart, JA; Tutsch, K | 1 |
| da Fonseca, CO; Fischer, J; Futuro, D; Gattass, CR; Nagel, J; Quirico-Santos, T; Schwartsmann, G | 1 |
| Bardon, S; Martel, P; Picard, K | 1 |
1 review(s) available for perillyl alcohol and Disease Exacerbation
| Article | Year |
|---|---|
Anaplastic oligodendroglioma responding favorably to intranasal delivery of perillyl alcohol: a case report and literature review.
Topics: Administration, Inhalation; Administration, Intranasal; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Frontal Lobe; Humans; Karnofsky Performance Status; Magnetic Resonance Imaging; Middle Aged; Monoterpenes; Oligodendroglioma; Treatment Outcome | 2006 |
3 trial(s) available for perillyl alcohol and Disease Exacerbation
| Article | Year |
|---|---|
Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Monoterpenes; Neoplasm Metastasis; Treatment Outcome | 2002 |
Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Biotransformation; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endpoint Determination; Female; Humans; Middle Aged; Monoterpenes; Neoplasm Metastasis; Transforming Growth Factor beta1; Treatment Outcome | 2008 |
Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas.
Topics: Administration, Intranasal; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Blood-Brain Barrier; Brain Neoplasms; Dacarbazine; Disease Progression; Drug Administration Schedule; Enzyme Inhibitors; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Monoterpenes; Neoplasm Recurrence, Local; Oncogene Protein p21(ras); Signal Transduction; Survival Rate; Temozolomide; Transforming Growth Factor beta; Treatment Outcome | 2008 |
2 other study(ies) available for perillyl alcohol and Disease Exacerbation
| Article | Year |
|---|---|
Anti-thrombin as a prognostic biomarker candidate for patients with recurrent glioblastoma multiform under treatment with perillyl alcohol.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Central Nervous System Neoplasms; Disease Progression; Electrophoresis, Polyacrylamide Gel; Fibrin; Fibrinogen; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mass Spectrometry; Monoterpenes; Proteomics; Recurrence | 2008 |
Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Division; Cyclin D1; Cyclohexenes; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Limonene; Monoterpenes; Terpenes; Tumor Cells, Cultured | 1998 |